Purpose: To investigate whether variants in the complement factor H (CFH) gene are associated with polypoidal choroidal vasculopathy (PCV).
Design: Cross-sectional study.
Participants: A case-control group of 130 PCV subjects and 173 unrelated controls.
Methods: We conducted an association analysis between CFH variants and PCV in a Japanese population, genotyping 12 tag single nucleotide polymorphisms (SNPs)-including rs3753394, rs800292 (I62V), and rs1061170 (Y402H)-that are highly representative of the common genetic variation in the CFH region. Genotyping was performed using TaqMan technology.
Main Outcome Measures: Allele and haplotype frequencies of the CFH variants.
Results: A highly significant association with PCV was observed across the CFH region. The strongest association was observed at I62V (P = 1.7 x 10(-7)). Six other SNPs (rs3753394, rs6680396, rs1410996, rs2284664, rs1329428, and rs1065489) also showed significant association (10(-3) < P < 10(-6)). These associations became nonsignificant after accounting for rs800292 in a conditional logistic regression analysis. A significant omnibus haplotype association was detected in the entire CFH region (omnibus P = 1.6 x 10(-5) at 7 degrees of freedom). Conditional haplotype-based likelihood ratio tests revealed that the significant omnibus haplotype association disappeared when it was estimated conditional on I62V (omnibus P = 0.20, 6 degrees of freedom, post-I62V dependency), whereas the omnibus haplotype association remained significant when it was estimated conditional on any SNP other than I62V. These findings indicate that multiple observed effects were caused by linkage disequilibrium with I62V, and that this variant fully accounts for the association signals observed at the set of SNPs examined at this locus.
Conclusions: The present study provides evidence that the complement pathway plays a substantial role in the pathogenesis of PCV. The nonsynonymous variant I62V is a plausible candidate for a causal polymorphism leading to the development of PCV, given its potential for functional consequences on the CFH protein and our own statistical evidence.
Financial Disclosure(s): The authors have to proprietary or commercial interest in any materials discussed in this article.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ophtha.2008.11.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A mutant complement factor H (W1183R) enhances proteolytic cleavage of von Willebrand factor by ADAMTS-13 under shear.
J Thromb Haemost
January 2025
Department of Pathology and Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Institute of Reproductive Medicine and Developmental Sciences, The University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address:
Background: A loss-of-functional mutation (W1183R) in human complement factor H (CFH) is associated with complement-associated hemolytic uremic syndrome; mice carrying a similar mutation (W1206R) in CFH also develop thrombotic microangiopathy but its plasma von Willebrand factor (VWF) multimer sizes were dramatically reduced. The mechanism underlying such a dramatic change in plasma VWF multimer distribution in these mice is not fully understood.
Objectives: To determine the VWF and CFH interaction and how CFH proteins affect VWF multimer distribution.
Socioeconomic position, psychiatric medical treatment and risk of breast cancer recurrence and mortality: A Danish population-based cohort study.
Cancer Epidemiol
February 2025
Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital, Aarhus University, Olof Palmes Allé 43-45, Aarhus N 8200, Denmark. Electronic address:
Background: Breast cancer patients with low socioeconomic position (SEP) have a higher risk of recurrence and mortality. We examined the extent to which prior psychiatric medication impacted this association.
Methods: We conducted a cohort study of premenopausal women diagnosed with breast cancer in Denmark from 2002 to 2011 (n = 5847), linking data from Denmark's nationwide population-based health registries on breast cancer diagnosis, treatment, psychiatric medication prescriptions and SEP indicators (marital status, cohabitation, income, education and employment).
Evaluating the capacity of tertiary general hospitals in Beijing to prevent and treat respiratory infectious diseases: a delphi study.
BMC Infect Dis
December 2024
Beijing Friendship Hospital, Capital Medical University, No.95 Yongan Street, Xicheng District, Beijing, 100050, China.
Background: The capacity of tertiary general hospitals to prevent and treat respiratory infectious diseases plays a key role in effectively containing the spread of major epidemics within hospitals and ensuring early treatment for patients. This, in turn, helps control the transmission of diseases at the societal level and safeguard public health. However, there is a lack of detailed indicators for assessing hospitals' capacity in this area, which makes it difficult to evaluate and manage practices.
View Article and Find Full Text PDFAssessing the uptake of infertility core outcome set in IVF randomized controlled trials.
Hum Reprod
January 2025
Research Center of Clinical Epidemiology, Peking University Third Hospital, Haidian District, Beijing, China.
Study Question: Do the infertility core outcome set and standardized definitions affect the outcome selection for randomized controlled trials, and what aspects should be further improved in the future?
Summary Answer: Intrauterine pregnancy demonstrated the highest uptake level, whereas others were low, especially in neonatal outcomes; as time progresses, the target sample size increases, and with prospective registration, the consistency between outcomes reported in registrations and infertility core outcome set improves significantly.
What Is Known Already: The infertility core outcome set, published on 30 November 2020, aims to standardize outcome reporting and prevent selective reporting bias; however, there is a paucity of research evaluating its actual adoption, which is crucial for the timely promotion of transparency, standardization, adjustment of development strategies, and efficient resource utilization.
Study Design, Size, Duration: This cross-sectional study included 1673 eligible randomized controlled trial registrations for infertility in 18 registries from March 2004 to July 2024 based on registry entries.
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Lancet Infect Dis
January 2025
Rare and Imported Pathogens Laboratory, UKHSA, Porton Down, Salisbury SP4 0JG, UK; Department of Clinical Virology, University College London NHS Hospitals Trust, London, UK. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!